<p>With multiple regimens available for advanced EGFRm NSCLC, selecting the best regimen for an individual patient is key. Jorge Nieva, MD, tells host Aakash Desai, MD, MPH, that the question<br>
shouldn’t be about who needs more efficacy, but rather understanding a patient’s personality and goals.</p>


<description>&lt;p&gt;With multiple regimens available for advanced EGFRm NSCLC, selecting the best regimen for an individual patient is key. Jorge Nieva, MD, tells host Aakash Desai, MD, MPH, that the question
shouldn’t be about who needs more efficacy, but rather understanding a patient’s personality and goals.&lt;/p&gt;
</description>

With multiple regimens available for advanced EGFRm NSCLC, selecting the best regimen for an individual patient is key. Jorge Nieva, MD, tells host Aakash Desai, MD, MPH, that the questionshouldn’t be about who needs more efficacy, but rather understanding a patient’s personality and goals.

Oncology News Central Peer-Spectives

“Is the Juice Worth the Squeeze?”: Treatment Intensification for Advanced EGFRm NSCLC

“Is the Juice Worth the Squeeze?”: Treatment Intensification for Advanced EGFRm NSCLC

Description